eurofins integrated cardiac proarrythmic risk assessment under the cipa initiative
Published 4 years ago • 419 plays • Length 47:54Download video MP4
Download video MP3
Similar videos
-
36:18
integrated cardiac proarrythmic risk assessment under the cipa initative [2020 jsps seminar]
-
40:13
cardiac proarrhythmic risk assessment using human ipsc-derived cardiomyocytes - session 1
-
42:06
cardiac proarrhythmic risk assessment using human ipsc-derived cardiomyocytes - session 2
-
50:56
high-throughput assessment of compound-induced cardiotoxicity using human ipsc-derived cardiomyocyte
-
21:40
validation of htp assays using human ipsc-derived cardiomyocytes to assess cardiotoxic compounds
-
55:18
eurofins integrated drug discovery webinar
-
21:36
the cipa initiative - how it will change the way we do drug discovery in the future
-
59:39
cipa initiative and validation of high-throughput methods to characterize compound effects
-
1:05:12
eurofins discovery services
-
59:39
cipa initiative and validation of high-throughput methods to characterize compound effects
-
5:53
europcr 22: mitraclip in atrial functional mitral regurgitation
-
7:09
in silico modeling for the new cipa paradigm
-
1:06:19
webinar: making sense of the cipa initiative: a paradigm in cardiac safety
-
58:32
comprehensive identification of cardiovascular safety liabilities using a totality of evidence
-
52:12
eurofins panlabs safety screening webinar